{
    "Trade/Device Name(s)": [
        "CRYOcheck Hex LA",
        "Cryocheck Hex LA"
    ],
    "Submitter Information": "Precision BioLogic Inc.",
    "510(k) Number": "K193556",
    "Predicate Device Reference 510(k) Number(s)": [
        "K923731"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GFO"
    ],
    "Summary Letter Date": "October 23, 2020",
    "Summary Letter Received Date": "December 23, 2019",
    "Submission Date": "December 20, 2019",
    "Regulation Number(s)": [
        "21 CFR 864.7925"
    ],
    "Regulation Name(s)": [
        "Partial Thromboplastin Time Tests"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Lupus anticoagulant"
    ],
    "Specimen Type(s)": [
        "3.2% citrated human plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "STA-R Evolution"
    ],
    "Method(s)/Technology(ies)": [
        "Hexagonal-phase phospholipid neutralization test (HPNT)",
        "Silica-based lupus sensitive APTT assay"
    ],
    "Methodologies": [
        "Clot-based assay",
        "Integrated screening, confirmatory, and mixing test"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for CRYOcheck Hex LA kit, a qualitative test for detection of lupus anticoagulant in citrated plasma using hexagonal phase phospholipids.",
    "Indications for Use Summary": "For clinical laboratory use as a qualitative test kit to aid in the detection of lupus anticoagulants in 3.2% citrated human plasma by the application of hexagonal phase phospholipids; in vitro diagnostic use only.",
    "fda_folder": "Hematology"
}